In this episode, we explore the current clinical applications of poly adenosine diphosphate-ribose polymerase (PARP) inhibitors in cancer care, including their role, targeted cancers, and strategies for managing side effects of these agents. We also forecast where these agents may have additional utilization in the future. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.